Prognostic role of maternal neutrophil gelatinase-associated lipocalin in women with severe early-onset preeclampsia

Fetal Diagnosis and Therapy

Volumn 35, Issue 2, 2014, Pages 127-132

  Scazzochio, Elena ^a,b   Munmany, Meritxell ^a   Garcia, Laura ^a   Meler, Eva ^a   Crispi, Fatima ^a   Gratacos, Eduard ^a   Figueras, Francesc ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Early onset preeclampsia; Neutrophil gelatinase associated lipocalin

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ASPARTATE AMINOTRANSFERASE; CREATININE; HYDRALAZINE; LABETALOL; LACTATE DEHYDROGENASE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ECLAMPSIA; FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HOSPITAL ADMISSION; HUMAN; LIVER HEMATOMA; LUNG EDEMA; MAJOR CLINICAL STUDY; ONSET AGE; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANK SUM TEST; SEVERE EARLY ONSET PREECLAMPSIA; ANTIHYPERTENSIVE THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE DISEASE; BODY MASS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; LACTATE DEHYDROGENASE BLOOD LEVEL; MATERNAL AGE; MATERNAL PLASMA; PREDICTIVE VALUE; PRIMIPARA; SENSITIVITY AND SPECIFICITY; SUBCAPSULAR HEPATIC HEMATOMA; THROMBOCYTE COUNT; THROMBOPHILIA;

ACUTE-PHASE PROTEINS; FEMALE; HELLP SYNDROME; HUMANS; LIPOCALINS; MATERNAL MORTALITY; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS; PROTO-ONCOGENE PROTEINS;

EID: 84896142991     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000356499     Document Type: Article

References (37)

1. Duley L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-137.
2. World Health Organization, Estimates of Maternal Mortality: A New Approach by WHO and UNICED. Geneva, World Health Organization, 1996.
3. Eclampsia Trial Collaborative Group: Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455-1463.
4. Tang LC, Kwok AC, Wong AY, Lee YY, Sun KO, So AP: Critical care in obstetrical patients: an eight-year review. Chin Med J (Engl) 1997; 110: 936-941. (Pubitemid 128515851)
5. Crispi F, Dominguez C, Llurba E, Martin-Gallan P, Cabero L, Gratacos E: Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006; 195: 201-207. (Pubitemid 43927524)
6. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005; 308: 1592-1594. (Pubitemid 40807500)
7. Meler E, Figueras F, Bennasar M, Gomez O, Crispi F, Gratacos E: The prognostic role of uterine artery Doppler investigation in patients with severe early-onset preeclampsia. Am J Obstet Gynecol 2011; 202: 559.e551-e554.
8. Kovo M, Schreiber L, Ben-Haroush A, Gold E, Golan A, Bar J: The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction. Prenat Diagn 2012; 32: 632-637.
9. Sibai BM, Mercer BM, Schiff E, Friedman SA: Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994; 171: 818-822. (Pubitemid 24312370)
10. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ: Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990; 76: 1070-1075.
11. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A: Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54: 1012-1024.
12. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238. (Pubitemid 40469655)
13. McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ: Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis 2010; 55: 1026-1039.
14. Stillman IE, Karumanchi SA: The glomerular injury of preeclampsia. J Amn Soc Nephrol 2007; 18: 2281-2284. (Pubitemid 47203843)
15. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM: Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008; 359: 800-809.
16. Devarajan P: Neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 2010; 15: 419-428.
17. D'Anna R, Baviera G, Giordano D, Todarello G, Corrado F, Buemi M: Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. Acta Obstet Gynecol Scand 2008; 87: 1370-1373.
18. D'Anna R, Baviera G, Giordano D, Russo S, Dugo N, Santamaria A, Corrado F: First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. Prenat Diagn 2009; 29: 1066-1068.
19. D'Anna R, Baviera G, Giordano D, Todarello G, Russo S, Recupero S, Bolignano D, Corrado F: Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand 2010; 89: 275-278.
20. Youssef A, Righetti F, Morano D, Rizzo N, Farina A: Uterine artery doppler and biochemical markers (PAPP-A, PIGF, SFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (34 weeks) pre-eclampsia. Prenat Diagn 2011; 31: 1141-1146.
21. Robinson HP, Fleming JE: A critical evaluation of sonar 'crown-rump length' measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
22. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:9-14.
23. Figueras F, Meler E, Iraola A, Eixarch E, Coll O, Figueras J, Francis A, Gratacos E, Gardosi J: Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol Reprod Biol 2008; 136: 20-24.
24. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
25. von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Cote AM, Douglas MJ, Gruslin A, Hutcheon JA, Joseph KS, Kyle PM, Lee T, Loughna P, Menzies JM, Merialdi M, Millman AL, Moore MP, Moutquin JM, Ouellet AB, Smith GN, Walker JJ, Walley KR, Walters BN, Widmer M, Lee SK, Russell JA, Magee LA: Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011; 377: 219-227.
26. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N: Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994; 83: 799-807. (Pubitemid 24043742)
27. Anwaar I, Gottsater A, Ohlsson K, Mattiasson I, Lindgarde F: Increasing levels of leukocytederived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia. Cerebrovasc Dis 1998; 8: 310-317. (Pubitemid 28491091)
28. Elneihoum AM, Falke P, Hedblad B, Lindgarde F, Ohlsson K: Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis 1997; 131: 79-84. (Pubitemid 27240100)
29. Dent CL, Ma Q, Dastrala S, Bennett M, Mitsnefes MM, Barasch J, Devarajan P: Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007; 11:R127.
30. Giasson J, Li GH, Chen Y: Neutrophil gelatinase-associated lipocalin (NGAL) as a new biomarker for non-acute kidney injury (AKI) diseases. Inflamm Allergy Drug Targets 2011; 10: 272-282.
31. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R: Pre-eclampsia. Lancet 2010; 376: 631-644.
32. Audibert F, Friedman SA, Frangieh AY, Sibai BM: Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996; 175: 460-464. (Pubitemid 26391008)
33. Hertig A, Fort J, Lefevre G, Chabbert-Buffet N, Uzan M, Rondeau E, Rozenberg P: Soluble endoglin in preeclamptic patients with or without HELLP syndrome. Am J Obstet Gynecol 2010; 202: 594.e591-e594.
34. MacKay AP, Berg CJ, Atrash HK: Pregnancyrelated mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97: 533-538.
35. Sibai BM: Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol 2011; 205: 191-198.
36. Laskin S, Payne B, Hutcheon JA, Qu Z, Douglas MJ, Ford J, Lee T, Magee LA, von Dadelszen P: The role of platelet counts in the assessment of inpatient women with preeclampsia. J Obstet Gynaecol Can 2011; 33: 900-908.
37. Kim SM, Park JS, Norwitz ER, Jung HJ, Kim BJ, Park CW, Jun JK: Circulating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia. Reprod Sci 2013; 20: 1083-1089.